Tribunal rules in favor of assessee on transfer pricing adjustments, criticizes Bright Line Test

The Tribunal ruled in favor of the assessee, disallowing the transfer pricing adjustment on Advertising, Marketing, and Promotion (AMP) expenses, as they were not considered international transactions. The Tribunal also allowed depreciation on building assets and non-compete fees, rejecting the disallowance of payments to doctors and convention expenses. The Tribunal criticized the use of the Bright Line Test (BLT) and upheld the Transactional Net Margin Method (TNMM) for determining arm's length prices. The appeal was partly allowed, with several grounds dismissed as general or consequential.

---

---

Issues Involved:
1. Assessment of total income.
2. Transfer pricing adjustment on Advertising, Marketing, and Promotion (AMP) expenses.
3. Determination of AMP as an international transaction.
4. Promotion of Associated Enterprise's (AE) brand in India.
5. Application of Transactional Net Margin Method (TNMM) and Bright Line Test (BLT).
6. Selection of comparable companies for benchmarking AMP expenses.
7. Classification of certain expenses as AMP expenses.
8. Disallowance of depreciation on building.
9. Disallowance of payments to doctors and convention expenses.
10. Levy of interest under sections 234B, 234C, and 234D of the Income Tax Act.
11. Initiation of penalty under section 271(1)(c) of the Income Tax Act.
12. Depreciation on non-compete fee.

Detailed Analysis:

1. Assessment of Total Income:
The assessee challenged the assessment of total income at Rs. 86,47,57,590 against Rs. 36,01,57,620 as computed by the assessee. This issue was deemed general and required no adjudication.

2. Transfer Pricing Adjustment on AMP Expenses:
The assessee contested the transfer pricing adjustment of Rs. 23,58,61,099 on AMP expenses. The Tribunal referred to its previous order in the assessee’s own case for A.Y. 2011-12, which concluded that AMP expenses should not be treated as an international transaction. The Tribunal reiterated that AMP expenditure incurred by the assessee was not an international transaction and disallowed the adjustment.

3. Determination of AMP as an International Transaction:
The Tribunal held that AMP expenses incurred by the assessee were not international transactions. It emphasized that there was no agreement between the assessee and its AE for sharing AMP expenses, and any incidental benefit to the AE did not constitute an international transaction.

4. Promotion of AE’s Brand in India:
The Tribunal noted that the assessee was using the established Medtronic brand for its business, and any benefit to the AE was incidental. Thus, AMP expenses were not incurred for promoting the AE’s brand.

5. Application of TNMM and BLT:
The Tribunal criticized the application of the Bright Line Test (BLT) by the TPO, stating it was not a prescribed method under the Act and Rules. It upheld the use of the Transactional Net Margin Method (TNMM) for determining the arm’s length price of trading transactions, including AMP expenses.

6. Selection of Comparable Companies for Benchmarking AMP Expenses:
The Tribunal found fault with the TPO’s selection of comparables, noting that the same set of comparables should be used for benchmarking both import of trading goods and AMP expenses. It rejected the ad hoc selection of comparables by the TPO.

7. Classification of Certain Expenses as AMP Expenses:
The Tribunal addressed the inclusion of personnel costs, travel expenses, and depreciation on equipment as part of AMP expenses. It ruled that these were routine business expenses and should not be classified as AMP expenses. It also rejected the TPO’s method of considering 80% of manpower expenses and travel costs as AMP expenses.

8. Disallowance of Depreciation on Building:
The Tribunal referred to its previous orders in the assessee’s own case, which allowed depreciation on building assets even after the discontinuation of the manufacturing unit. It ruled in favor of the assessee, allowing the depreciation claim.

9. Disallowance of Payments to Doctors and Convention Expenses:
The Tribunal examined the disallowance of Rs. 27,11,48,553 on payments to doctors, citing MCI regulations and CBDT Circular No. 05/2012. It noted that MCI regulations apply only to medical practitioners, not to medical device companies like the assessee. The Tribunal cited various High Court rulings and previous Tribunal decisions to conclude that such expenses were allowable business expenditures and not prohibited by law.

10. Levy of Interest Under Sections 234B, 234C, and 234D:
The Tribunal dismissed the grounds related to the levy of interest under sections 234B, 234C, and 234D as consequential and not requiring separate adjudication.

11. Initiation of Penalty Under Section 271(1)(c):
The Tribunal did not specifically address the initiation of penalty under section 271(1)(c) in the detailed analysis provided.

12. Depreciation on Non-compete Fee:
The Tribunal admitted the additional ground raised by the assessee regarding depreciation on non-compete fees. It directed the Assessing Officer to allow depreciation on the payment made for non-compete fees, treating it as capital expenditure, following its previous orders in the assessee’s own case.

Conclusion:
The Tribunal ruled in favor of the assessee on most grounds, particularly concerning the non-recognition of AMP expenses as international transactions and the allowance of depreciation on building and non-compete fees. The appeal was partly allowed, with several grounds being dismissed as general or consequential.

---